David Duggan profile picture
315 464-8200

David Duggan, MD

CURRENT APPOINTMENTS

Distinguished Service Professor of Medicine

SPECIALTIES

Internal Medicine
Medical Oncology
Hematology

LANGUAGES

English

PATIENT TYPE

Adults

RESEARCH PROGRAMS AND AFFILIATIONS

Medicine

RESEARCH INTERESTS

Clinical trials in cancer; Hodgkin's Disease, Lymphoma and  Leukemia.

ASSOCIATIONS / MEMBERSHIPS

American College of Physicians (ACP)
American Society of Clinical Oncology - ASCO
American Society of Hematology (ASH)

EDUCATION

Fellowship: Tufts-New England Medical Center, 1985, Hematology-Oncology
Residency: Tufts-New England Medical Center, 1982, Internal Medicine
MD: SUNY Health Science Center at Syracuse, 1979
BA: Hamilton College, 1975, Biology

RESEARCH ABSTRACT

Selected References

Parnes HL, Cirrincione C, Aisner J, Berry DA, Allen SL, Abrams J, Chuang E, Cooper MR, Perry MC, Duggan DB, Szatrowski TP, Henderson IC, Norton L. Phase III study of cyclophosphamide, doxorubicin, and fluorouracil (CAF) plus leucovorin versus CAF for metastatic breast cancer: Cancer and Leukemia Group B 9140. J Clin Oncol. 2003 May 1;21(9):1819-24.

Henderson IC, Berry DA, Demetri GD, Cirrincione CT, Goldstein LJ, Martino S, Ingle JN, Cooper MR, Hayes DF, Tkaczuk KH, Fleming G, Holland JF, Duggan DB, Carpenter JT, Frei E 3rd, Schilsky RL, Wood WC, Muss HB, Norton L. Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer. J Clin Oncol. 2003 Mar 15;21(6):976-83.

Duggan DB, Petroni GR, Johnson JL, Glick JH, Fisher RI, Connors JM, Canellos GP, Peterson BA. Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial. J Clin Oncol. 2003 Feb 15;21(4):607-14.

Hayes DF, Yamauchi H, Broadwater G, Cirrincione CT, Rodrigue SP, Berry DA, Younger J, Panasci LL, Millard F, Duggan DB, Norton L, Henderson IC. (HER-2) extracellular domain as a prognostic factor in patients with metastatic breast cancer: Cancer and Leukemia Group B Study 8662.Clin Cancer Res. 2001 Sep;7(9):2703-1

PUBLICATIONS

Link to PubMed (Opens new window. Close the PubMed window to return to this page.)